Sterling Pharma, a provider of active pharmaceutical ingredients and formulations completed the acquisition of CiVentiChem's US facility, a manufacturer of chemical preparations. Financial terms were not disclosed. The acquisition of CiVentiChem US is the latest step in Sterling Pharma Solutions’ ongoing growth strategy to allow it to continue providing high service levels to its global customer base. “We’re delighted to announce our acquisition of CiVentiChem in the US. We’ve been keen to expand our presence in the US market and the site’s capabilities complement our current service offering." Kevin Cook, Sterling CEO.